Pharma-Bio Serv (PBSV) Accounts Payables (2010 - 2026)

Pharma-Bio Serv's Accounts Payables history runs 16 years deep, the most recent figure standing at $978541.0 for Q2 2026.

• Accounts Payables for Q2 2026 came in at $978541.0, up 4.33% year-over-year; the trailing twelve-month figure through Apr 2026 was $978541.0 (up 4.33% YoY), and the FY2025 annual result was $991169.0, down 12.1% from the prior year.
• Accounts Payables came in at $978541.0 for Q2 2026 at Pharma-Bio Serv, up from $869964.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.7 million in Q3 2022 to a low of $869964.0 in Q1 2026.
• A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 33.78% in 2024 and increased 4.33% in 2026, its largest moves.
• Over 5 years, Accounts Payables stood at $1.6 million in 2022, then retreated by 9.95% to $1.5 million in 2023, then slipped by 23.15% to $1.1 million in 2024, then dropped by 12.1% to $991169.0 in 2025, then declined by 1.27% to $978541.0 in 2026.
• The last three Accounts Payables figures came in at $978541.0 (Q2 2026), $869964.0 (Q1 2026), and $991169.0 (Q4 2025), per Business Quant data.